From the annual report 30/4: In the forthcoming year, submission of our final pre-market approval (PMA) application to the FDA, and the official publication of theSOLVE dataset in a peer-reviewed medical journal will be important milestones
If they have published it, it hasn't been announced to my knowledge, and going on the above I think there would be an announcement, even if it wasn't price sensitive.
From the annual report 30/4: In the forthcoming year, submission...
Add EBR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.14 |
Change
0.040(3.64%) |
Mkt cap ! $351.2M | |||
| Open | High | Low | Value | Volume |
| $1.15 | $1.15 | $1.09 | $138.3K | 124.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1249 | $1.09 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.14 | 4736 | 1 |
View Market Depth
| Last trade - 16.10pm 23/08/2024 (20 minute delay) ? |
| EBR (ASX) Chart |